Displaying 31 - 40 of 84 for Cancer - All
  • Head and Neck Squamous Cell Carcinoma Study (H-39773)
    • The purpose of this research is to see whether metformin can improve the response rate in patients undergoing chemotherapy and radiation for squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx.
  • HPV-Related Cancer Study (H-36021)
    • The purpose of this study is to find the biggest dose of HPVSTs that is safe, to see how long they last in the body, to learn what the side effects are and to see if the HPVSTs will help people with HPV associated cancers.
  • Immune Landscape of Thoracic Malignancies (H-35782)
    • The purpose of this clinical trial is to collect information on the types of immune cells found in and around the tumor site(s).
  • Improving Self-Management in Head and Neck Cancer (H-38984)
    • The purpose of this study is to evaluate a program that we have developed for head and neck cancer patients and their partners.
  • Locally Advanced Rectal Cancer, NRG-GI002 (H-41594)
    • This randomized phase II trial studies how well veliparib works with combination chemotherapy and radiation therapy in treating patients with rectal cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). 
  • Longitudinal Testicular Cancer Database (H-19072)
    • The purpose of this study is to assess an outcome of patients suffering from germ cell testicular cancer.
  • Lung-MAP Study (H-35339)
    • This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid "Master Protocol" (S1400).
  • MABEL Study (H-35253)
    • In this study, we want to find out if we can use banked MABEL CTLs to treat HD or NHL, T/NK-lymphoproliferative disease and severe chronic active Epstein Barr Virus (CAEBV).
  • MAGENTA Study (H-40466)
    • This research study combines antibodies and T cells to fight a type of blood cancer called T-cell leukemia or lymphoma (lymph gland cancer).
  • MAGNIFY Study (H-35785)
    • The purpose of this study is to learn how well the combination of lenalidomide (an investigational drug) and a medicine called rituximab works in controlling some forms of non-Hodgkin lymphoma (NHL).